摘要
背景:白质疏松症(Leukoaraisis,LA)是老年人常见的影像学表现,常伴有多种临床疾患,包括不明原因的头晕。LA的发病机制是多因素的,脑微循环功能障碍导致慢性低灌注和组织丢失,并伴有氧化应激。目的:分析LA患者的氧化应激标志物。方法:连续55例LA患者,男33例,中位年龄75岁.在33名患有LA和不明原因头晕的患者中,我们进行了一项开放式研究,以评估60天补充多酚化合物是否可以改变这些生物标志物并影响生活质量,用眩晕障碍量表(DHI)进行分析。结果:在基线状态下,血氧化应激参数值超出正常范围,与正常对照组比较,差异有显着性(P<0.05)。经过两个月的补充,我们观察到高级氧化蛋白产物值显著下降,DHI值显著改善。结论:氧化应激生物标志物可用于检测LA氧化还原失衡,为监测病情及治疗反应提供无创工具。
关键词: 白质疏松症,脑小血管疾病,头晕,氧化应激,多酚,DHI。
Current Molecular Medicine
Title:Oxidative Stress in Cerebral Small Vessel Disease Dizziness Patients, Basally and After Polyphenol Compound Supplementation
Volume: 18 Issue: 3
关键词: 白质疏松症,脑小血管疾病,头晕,氧化应激,多酚,DHI。
摘要: Background: Leukoaraiosis (LA) is a common radiological finding in elderly, frequently associated with several clinical disorders, including unexplained dizziness. The pathogenesis of LA is multifactorial, with a dysfunction of cerebral microcirculation resulting in chronic hypoperfusion and tissue loss, with oxidative stress involved in this cascade.
Objective: The aim of this study was to analyse some oxidative stress biomarkers in a cohort of LA patients.
Method: Fifty-five consecutive patients (33 males, median age 75 years) with LA were recruited. In a subgroup of 33 patients with LA and unexplained dizziness, we have then performed an open study to evaluate if 60-day supplementation with a polyphenol compound may modify these biomarkers and influence quality of life, analysed with the Dizziness Handicap Inventory (DHI) scale.
Results: At baseline, blood oxidative stress parameters values were outside normal ranges and compared to matched healthy controls. After the two months supplementation, we observed a significant decrement of advanced oxidation protein products values and a significant improvement of DHI.
Conclusion: Oxidative stress biomarkers may be useful to detect redox imbalance in LA and to provide non-invasive tools to monitor disease status and response to therapy.
Export Options
About this article
Cite this article as:
Oxidative Stress in Cerebral Small Vessel Disease Dizziness Patients, Basally and After Polyphenol Compound Supplementation, Current Molecular Medicine 2018; 18 (3) . https://dx.doi.org/10.2174/1566524018666180720165055
DOI https://dx.doi.org/10.2174/1566524018666180720165055 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biological Activities of Yarrow Species (Achillea spp.)
Current Pharmaceutical Design Advances in Tissue and Organ Replacement
Current Stem Cell Research & Therapy Update on the Pharmacological Treatment of Alzheimers Disease
Current Neuropharmacology Towards Newer Molecular Targets for Chronic Diabetic Complications
Current Vascular Pharmacology Membrane and Soluble Forms of Endoglin in Preeclampsia
Current Molecular Medicine Lipid Lowering Drugs and Gallstones: A Therapeutic Option?
Current Pharmaceutical Design Human Saphenous Vein and Coronary Bypass Surgery: Scanning Electron Microscopy of Conventional and ‘No-Touch’ Vein Grafts
Vascular Disease Prevention (Discontinued) Imaging with Raman Spectroscopy
Current Pharmaceutical Biotechnology Meet Our Editorial Board Member:
Reviews on Recent Clinical Trials Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz
Current HIV Research Safety Aspects of Statins: Which Factors Create the Adverse Effects of Statins
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Cardiac Effects of HDL and Its Components on Diabetic Cardiomyopathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Hypercoagulability and Nephrotic Syndrome
Current Vascular Pharmacology Association Between the Levels of Circulating Adhesion Molecules and Biopterins in Type-2 Diabetic Normotensive Patients Adhesion Molecules and Biopterins
Endocrine, Metabolic & Immune Disorders - Drug Targets Arrhythmia Pharmacogenomics: Methodological Considerations
Current Pharmaceutical Design Hepatotoxicity of Antiretroviral Drugs
Current Pharmaceutical Design Managing the Suicidal Risk in Pregnant Women with Severe and Persistent Psychiatric Disorder: Focus on Antisuicidal Drugs and Somatic Interventions
Current Psychiatry Reviews Medication-Induced Nephrotoxicity in Older Patients
Current Drug Metabolism Potential Effect of Anti-Tumour Necrosis Factor-Alpha Treatment on Reducing the Cardiovascular Risk Related to Rheumatoid Arthritis
Current Vascular Pharmacology Recent Advances and Patents on Nanoscale Systems and Triggerable Drug Delivery in Medical Devices
Recent Patents on Biomedical Engineering (Discontinued)